CN1288384A - 用于预防哺乳动物粘膜炎莫拉氏(布拉汉氏)菌感染的脂寡糖疫苗 - Google Patents

用于预防哺乳动物粘膜炎莫拉氏(布拉汉氏)菌感染的脂寡糖疫苗 Download PDF

Info

Publication number
CN1288384A
CN1288384A CN99802142A CN99802142A CN1288384A CN 1288384 A CN1288384 A CN 1288384A CN 99802142 A CN99802142 A CN 99802142A CN 99802142 A CN99802142 A CN 99802142A CN 1288384 A CN1288384 A CN 1288384A
Authority
CN
China
Prior art keywords
dlos
los
vaccine
morazella catarrhalis
hmp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN99802142A
Other languages
English (en)
Chinese (zh)
Inventor
古新星
J·B·罗宾斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Government Of Usa Represented By Secretary Of Department Of
US Department of Health and Human Services
Original Assignee
Government Of Usa Represented By Secretary Of Department Of
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Government Of Usa Represented By Secretary Of Department Of filed Critical Government Of Usa Represented By Secretary Of Department Of
Publication of CN1288384A publication Critical patent/CN1288384A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A61K39/1045—Moraxella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
CN99802142A 1998-01-13 1999-01-12 用于预防哺乳动物粘膜炎莫拉氏(布拉汉氏)菌感染的脂寡糖疫苗 Pending CN1288384A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7148398P 1998-01-13 1998-01-13
US60/071,483 1998-01-13

Publications (1)

Publication Number Publication Date
CN1288384A true CN1288384A (zh) 2001-03-21

Family

ID=22101617

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99802142A Pending CN1288384A (zh) 1998-01-13 1999-01-12 用于预防哺乳动物粘膜炎莫拉氏(布拉汉氏)菌感染的脂寡糖疫苗

Country Status (9)

Country Link
EP (1) EP1047447A1 (pt)
JP (1) JP2002509115A (pt)
KR (1) KR20010034124A (pt)
CN (1) CN1288384A (pt)
AU (2) AU2221299A (pt)
BR (1) BR9906902A (pt)
CA (1) CA2315746A1 (pt)
IL (1) IL136903A0 (pt)
WO (1) WO1999036086A1 (pt)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104592365A (zh) * 2013-11-01 2015-05-06 中国人民解放军军事医学科学院毒物药物研究所 梭曼抗原、梭曼疫苗及其用途
CN111542339A (zh) * 2017-11-06 2020-08-14 斯蒂芬·罗杰·格雷夫斯 疫苗

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040126381A1 (en) 1996-04-23 2004-07-01 Xin-Xing Gu Intranasal immunization with detoxified lipooligosaccharide from nontypeable haemophilus influenzae or moraxella
WO2002089839A1 (en) * 2001-05-03 2002-11-14 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Intranasal immunization with detoxified lipooligosaccharide from nontypeable haemophilus influenzae or moraxella catarrhalis
US6391313B1 (en) * 1999-07-15 2002-05-21 Aventis Pasteur Limited Multi-component vaccine to protect against disease caused by Haemophilus influenzae and Moraxella catarrhalis
WO2006085910A2 (en) * 2004-06-04 2006-08-17 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Endotoxin-free moraxella catarrhalis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998053851A1 (en) * 1997-05-28 1998-12-03 University Of Iowa Research Foundation Laft mutants of pathogenic gram-negative bacteria

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104592365A (zh) * 2013-11-01 2015-05-06 中国人民解放军军事医学科学院毒物药物研究所 梭曼抗原、梭曼疫苗及其用途
CN104592365B (zh) * 2013-11-01 2019-06-14 中国人民解放军军事医学科学院毒物药物研究所 梭曼抗原、梭曼疫苗及其用途
CN111542339A (zh) * 2017-11-06 2020-08-14 斯蒂芬·罗杰·格雷夫斯 疫苗
CN111542339B (zh) * 2017-11-06 2024-06-04 Ozq私人有限公司 疫苗

Also Published As

Publication number Publication date
WO1999036086A1 (en) 1999-07-22
JP2002509115A (ja) 2002-03-26
BR9906902A (pt) 2000-10-17
AU2003200964A1 (en) 2003-06-12
AU2003200964B2 (en) 2004-11-11
CA2315746A1 (en) 1999-07-22
EP1047447A1 (en) 2000-11-02
KR20010034124A (ko) 2001-04-25
AU2221299A (en) 1999-08-02
AU2003200964A8 (en) 2003-06-12
IL136903A0 (en) 2001-06-14

Similar Documents

Publication Publication Date Title
US6558677B2 (en) Vaccine against gram negative bacteria
FI112032B (fi) Menetelmä ureaasipohjaisen rokotteen valmistamiseksi Helicobacter-infektiota vastaan
JP6857962B2 (ja) 肺炎球菌ワクチンにおいて用いるための免疫原性組成物
US7491517B2 (en) Method of producing meningococcal meningitis vaccine for Neisseria meningitidis serotypes A,C,Y, and W-135
Frasch et al. Protection against group B meningococcal disease. III. Immunogenicity of serotype 2 vaccines and specificity of protection in a guinea pig model.
Ellis Vaccines: New approaches to immunological problems
CA2090673A1 (en) Vaccine compositions
JP2001510169A (ja) Ｂ型髄膜炎菌性ポーリンおよびＨ．ｉｎｆｌｕｅｎｚａｅ多糖体を含む免疫原性結合体
JPH05279399A (ja) タンパク質−ダイマー多糖結合体ワクチン
BE1025443B1 (fr) CONJUGUES nOMV-ANTIGENE ET LEUR UTILISATION
KR20170016360A (ko) 폴리사카라이드-단백질 접합체의 면역원성을 증진시키는 조성물 및 방법
HU211031B (en) Method for preparation of actinobacillus pleuropneumoniae vaccine
US6685949B1 (en) Lipooligosaccharide based vaccine for prevention of moraxella (branhamella)catarrhalis infections in humans
Medina et al. Fibronectin‐binding protein I of Streptococcus pyogenes is a promising adjuvant for antigens delivered by mucosal route
US10716847B2 (en) Haemophilus influenzae fusion protein and construction method and use thereof
CN1288384A (zh) 用于预防哺乳动物粘膜炎莫拉氏(布拉汉氏)菌感染的脂寡糖疫苗
JP6401148B2 (ja) 抗原および抗原の組み合わせ
EP0471954A2 (en) Immunogenic conjugates of nontoxic oligosaccharide derived from bordetella pertussis lipooligosaccharide
EP1572729B1 (en) Mutant frpb protein and refolding method
MX2008012664A (es) Composicion farmaceutica que comprende la proteina nmb0938.
RU2335505C2 (ru) Белок nmb0928 и его применение в фармацевтических композициях
RU2233172C2 (ru) Иммуногенный коньюгат полисахарид h. influenzae - порин менингококка группы b (варианты), способ его получения, фармацевтическая композиция и способ индукции иммунного ответа у животного в отношении h.influenzae
EP1977761A2 (en) Pharmaceutical compositions containing protein nma0939
CN114681601A (zh) 脑膜炎奈瑟氏球菌疫苗及其应用
MXPA00000556A (en) Immunogenic conjugates comprising a group b meningococcal porin and an h. influenzae

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1035150

Country of ref document: HK